Skip to main content

Higher CPAP Adherence Tied to Reduction in Cardiovascular Events

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Oct. 6, 2023 -- Adherence to continuous positive airway pressure (CPAP) treatment is associated with a reduced risk for cardiovascular event recurrence, according to a review published in the Oct. 3 issue of the Journal of the American Medical Association.

Manuel Sánchez-de-la-Torre, Ph.D., from the University of Lleida in Spain, and colleagues conducted a systematic literature review and meta-analysis to assess the effect of CPAP treatment for obstructive sleep apnea (OSA) on the risk for adverse cardiovascular events. The analysis included data from 4,186 individual participants with established cardiovascular disease and OSA (50.1 percent receiving CPAP with mean adherence of 3.1 hours per day).

The researchers found that for the main outcome of first major adverse cardiac and cerebrovascular event (MACCE), the CPAP and non-CPAP groups had a similar occurrence (hazard ratio, 1.01; 95 percent confidence interval, 0.87 to 1.17). However, with good adherence to CPAP (four or more hours per day), treatment was associated with a reduced recurrence risk for MACCE (hazard ratio, 0.69; 95 percent confidence interval, 0.52 to 0.92).

"Adherence to CPAP was associated with a reduced MACCE recurrence risk, suggesting that treatment adherence is a key factor in secondary cardiovascular prevention in patients with OSA," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older

TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.